We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-15.8%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$537M
AUM Growth
-$133M
Cap. Flow
-$47.6M
Cap. Flow %
-8.86%
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$10.5M
2
TFC icon
Truist Financial
TFC
+$8.46M
3
QCOM icon
Qualcomm
QCOM
+$8.04M
4
WBA
Walgreens Boots Alliance
WBA
+$4.59M
5
EOG icon
EOG Resources
EOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 13.14%
3 Consumer Discretionary 12.35%
4 Industrials 11.65%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEI icon
426
Douglas Emmett
DEI
$2.03B
$352K 0.07%
+15,719
New +$438K
GLBE icon
427
Global E Online
GLBE
$6.34B
$351K 0.07%
17,400
+1,800
+12% +$41.3K
LBRT icon
428
Liberty Energy
LBRT
$2.75B
$351K 0.07%
27,500
+12,100
+79% +$190K
CANO
429
DELISTED
Cano Health, Inc.
CANO
$350K 0.07%
799
+573
+254% +$299K
RCUS icon
430
Arcus Biosciences
RCUS
$3.5B
$348K 0.06%
+13,736
New +$336K
AGL icon
431
Agilon Health
AGL
$1.64B
$347K 0.06%
636
-384
-38% -$194K
AMC icon
432
AMC Entertainment Holdings
AMC
$2.24B
$339K 0.06%
2,500
-2,930
-54% -$426K
CAT icon
433
Caterpillar
CAT
$402B
$339K 0.06%
+1,897
New +$400K
CLDX icon
434
Celldex Therapeutics
CLDX
$2.8B
$337K 0.06%
+12,500
New +$363K
H icon
435
Hyatt Hotels
H
$18B
$337K 0.06%
+4,554
New +$395K
NVCR icon
436
NovoCure
NVCR
$1.97B
$337K 0.06%
+4,850
New +$365K
IONS icon
437
Ionis Pharmaceuticals
IONS
$9.25B
$336K 0.06%
+9,063
New +$342K
OMF icon
438
OneMain Financial
OMF
$7.08B
$336K 0.06%
8,978
-800
-8% -$34.6K
OPEN icon
439
Opendoor
OPEN
$3.71B
$336K 0.06%
73,785
+30,483
+70% +$201K
PI icon
440
Impinj
PI
$3.97B
$336K 0.06%
+5,725
New +$288K
FNV icon
441
Franco-Nevada
FNV
$41.4B
$335K 0.06%
2,549
+201
+9% +$29.7K
ROP icon
442
Roper Technologies
ROP
$37.1B
$334K 0.06%
847
+313
+59% +$136K
HQY icon
443
HealthEquity
HQY
$8.28B
$332K 0.06%
+5,400
New +$346K
THS
444
DELISTED
Treehouse Foods
THS
$332K 0.06%
+7,927
New +$291K
XRT icon
445
State Street SPDR S&P Retail ETF
XRT
$448M
$332K 0.06%
5,700
+1,080
+23% +$73.5K
PFGC icon
446
Performance Food Group
PFGC
$18B
$331K 0.06%
7,200
-8,300
-54% -$383K
WB icon
447
Weibo
WB
$1.92B
$331K 0.06%
14,300
+1,900
+15% +$42.6K
AEO icon
448
American Eagle Outfitters
AEO
$2.98B
$330K 0.06%
+29,500
New +$416K
RH icon
449
RH
RH
$3.4B
$329K 0.06%
+1,551
New +$460K
HLT icon
450
Hilton Worldwide
HLT
$75.3B
$327K 0.06%
2,935
-4,100
-58% -$567K

Similar funds

Bayesian Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.

  • Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
  • Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
  • Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
  • Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.